IRIS
LAI, PIERO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.300
Totale 7.300
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.300
Totale 7.300
Salva come PNG Salva come JPEG
Città #
Genova 5.104
Rapallo 952
Genoa 715
Vado Ligure 502
Bordighera 27
Totale 7.300
Salva come PNG Salva come JPEG
Nome #
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines 156
Age-related differences in the accuracy of web query-based predictions of influenza-like illness 148
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 147
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 142
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly 141
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study 140
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 135
An overview on the implementation of HPV vaccination in Europe 134
Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria 129
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 126
Cause of death among people with AIDS in Liguria (Italy). A different pattern for intravenous drug users? 125
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies 123
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation 123
Neisseria meningitidis B vaccines 122
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 121
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 119
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus 116
An overview of current and potential use of information and communication technologies for immunization promotion among adolescents 115
Long-term decline of (137)Cs concentration in honey in the second decade after the Chernobyl accident 114
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 112
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. 108
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 108
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young Italian females with normal cytology 107
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly. A matched case-control study 103
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 99
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 99
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage 97
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 94
Valutazione della tollerabilità del vaccino anti-HPV nelle donne liguri 92
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage. 91
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] 88
Virological investigation on aerosol from waste depuration plants 86
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 85
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 85
Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis 85
Development of a sensitive real-time PCR for simultaneous detection and subtyping of influenza A and B viruses 84
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 84
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review 84
Relevance of air condititioning for 222Radon concentration in commercial concerns of the Savona Province, Italy 83
VIROLOGICAL SURVEILLANCE AS A TOOL FOR ASSESSING HUMAN PAPILLOMAVIRUS VACCINATION 83
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 82
NEW VERSUS OLD MENINGOCOCCAL GROUP B VACCINES: HOW THE NEW ONES MAY BENEFIT INFANTS & TODDLERS 82
Prevalence of the Human Papillomavirus genotypes in Italian women undergoing voluntary cervical cancer screening: Evaluation of cumulative incidence from 16 to 26 years of age and evaluationof the effect of extending Italian vaccination policy with bivalent vaccine. 80
Utility of virosomal adjuvated influenza vaccines - a review of the literature. 79
PREVALENZA DEI TIPI DI HPV NELLE DONNE ITALIANE (16-26 ANNI) SOTTOPOSTE A SCREENING VOLONTARIO DEL CANCRO CERVICALE. VALUTAZIONE DELL’INCIDENZA CUMULATIVA E DELLA POSSIBILE ESTENSIONE DELLA VACCINAZIONE CON IL VACCINO BIVALENTE. 78
Aflunov: a prepandemic influenza vaccine 78
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 78
Relevance of main factor affecting Radon concentration in multi-storey buildings in Liguria (Northern Italy) 77
Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences 77
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 76
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®) 76
Live attenuated influenza vaccine-a review 75
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 74
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 74
Tubercolosis today: populations at risk 73
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. 72
Assessment and prevention of radioactive risk due to 222Radon in commercial concerns of Genoa 69
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs 69
Valutazione costi-benefici della vaccinazione influenzale in Liguria 67
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 67
Vaccination promotion within a framework of public health education 66
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains 66
Diminuzione delle coperture vaccinali per influenza: riflessi sull'epidemiologia stagionale 2012-13 in Liguria. 65
Hepatitis B immunization and anti-HBs quantitation: comparative performance of thirteen commercial immunoassays 64
Le vaccinazioni dell'adulto a rischio e dell'anziano 60
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 60
Tobacco smoking among students in an urban area in Northern Italy 59
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 57
Health Technology Assessment e vaccinazioni in Italia 56
Vaccinations for adults at risk and the elderly 55
Influenza vaccination of elderly: relaunch time 55
EPIDEMIOLOGIA DELL’INFLUENZA IN ITALIA DOPO LA PANDEMIA 2009-10. NECESSITÀ DI MIGLIORARE LE COPERTURE VACCINALI. 54
Today's influenza vaccines. Why an adjuvant is needed and How it works 52
Efficacia dei vaccini adiuvati e ricadute farmaco-economiche 51
The urban myth of the association between neurological disorders and vaccinations. 49
Meningococcal B vaccination strategies and their practical application in Italy 48
HTA in vaccine prevention: application to vaccinations against invasive diseases. 46
Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy 45
Influenza surveillance in the Italian region of Liguria in the winter of 1999-2000 by general practitioners and paediatricians: socio-economic implications 43
Influenza vaccination coverage in Italy in 1999-2013: impact on incidence of ILIs in the elderly. 42
Valutazione dell'impatto epidemiologico, sanitario ed aconomico della malattia da herpes zoster in Italia 41
Burden of typhoid fever and cholera: Similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas 41
UTILIZZO DELL'HTA IN PREVENZIONE VACCINALE: APPLICAZIONE ALLE VACCINAZIONI CONTRO LE MALATTIE INVASIVE 39
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy 39
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 35
Prevalenza dell’anti-HCV in pazienti plurioperati 29
Demographic and Socio-economic Determinants of Poor HIV-risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010-2016 29
Implementazione dei tassi di copertura vaccinale antinfluenzale nel personale sanitario dell'A.U.O. San Martino di Genova durante la stagione 2005-06 28
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons 26
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 25
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 23
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment 13
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons 11
Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine 8
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season 7
Totale 7.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.107
article - articoli 20.297
book - libri 0
conference - conferenze 3.552
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 258
Totale 48.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.553 0 0 0 0 138 196 261 107 186 364 212 89
2020/2021423 24 22 49 25 53 40 22 26 39 41 43 39
2021/2022995 21 98 74 96 48 45 55 252 63 77 41 125
2022/20231.138 110 81 16 106 175 211 4 76 176 6 164 13
2023/2024542 18 86 13 75 34 92 36 55 40 7 34 52
2024/2025533 54 133 60 130 156 0 0 0 0 0 0 0
Totale 7.423